Perfect Medical Health Management (1830) H2 2026 earnings summary

Executive summary

• Revenue declined 14.7% year-over-year to HK$962.3 million, but the rate of decline narrowed to 6.1% in the second half as market conditions improved.

• Profit attributable to equity holders fell 13.6% to HK$178.7 million, with a strong 27.1% period-on-period net profit increase in the second half.

• Net profit margin improved to 18.6%, and excluding a charitable donation, profit declined 10.6% with a margin of 19.2%.

• The Group maintained a 100%+ dividend payout ratio for the eleventh consecutive year.

Financial highlights

• EBITDA decreased 15.9% to HK$268.5 million, with EBITDA margin steady at 27.9%.

• Operating profit was HK$213.0 million, down 15.4%, with an operating margin of 22.1%.

• Net profit margin rose to 18.6% from 18.3% year-over-year.

• Cash and bank balances stood at HK$294.9 million, with no external bank borrowings.

• Net cash generated from operating activities was HK$339.5 million.

Outlook and guidance

• Early FY2027 performance in April and May 2026 was encouraging, supporting a positive outlook.

• Plans to leverage flagship network and high-efficacy services in Hong Kong as retail sentiment stabilizes.

• Outside Hong Kong, focus remains on premium positioning in Mainland China and operational optimization in Australia and Singapore.

• Continued integration of AI to drive customer acquisition, retention, and operational efficiency.